Central Venous Catheters for Hemodialysis-the Myth and the Evidence

被引:44
|
作者
Sohail, Mohammad Ahsan [1 ]
Vachharajani, Tushar J. [2 ,3 ]
Anvari, Evamaria [2 ,3 ]
机构
[1] Cleveland Clin, Dept Internal Med, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Nephrol & Hypertens, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA
来源
KIDNEY INTERNATIONAL REPORTS | 2021年 / 6卷 / 12期
关键词
central venous catheter; cuffed catheter; dialysis vascular access; hemodialysis; tunneled catheter; BLOOD-STREAM INFECTIONS; INTERNAL JUGULAR-VEIN; DIALYSIS VASCULAR ACCESS; TIP POSITION; RISK-FACTORS; CARDIAC-TAMPONADE; CLINICAL-OUTCOMES; SPLIT-TIP; PREVENTION; INSERTION;
D O I
10.1016/j.ekir.2021.09.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hemodialysis-central venous catheter (HD-CVC) insertion is a most often performed procedure, with approximately 80% of patients with end-stage kidney disease in the United States initiating kidney replacement therapy through a HD-CVC. Certain adverse events arising from HD-CVC placement, including catheter-related bloodstream infections (CR-BSIs), thrombosis, and central vein stenosis, can complicate the clinical course of patients and lead to considerable financial impact on the health care system. Medical professionals with different training backgrounds are responsible for performing this procedure, and therefore, comprehensive operator guidelines are crucial to improve the success rate of HD-CVC insertion and prevent complications. In this review article, we not only discuss the basic principles behind the use of HD-CVCs but also address frequently asked questions and myths regarding catheter asepsis, length selection, tip positioning, and flow rate assessment.
引用
收藏
页码:2958 / 2968
页数:11
相关论文
共 50 条
  • [21] Hemodialysis Central Venous Catheters as a Source of Inflammation and Its Implications
    Hung, Adriana M.
    Ikizler, T. Alp
    SEMINARS IN DIALYSIS, 2008, 21 (05) : 401 - 404
  • [22] Polyurethane central venous catheters for permanent hemodialysis access.
    Hirsch, DJ
    Bergen, P
    Jindal, KK
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0814 - A0814
  • [23] Central venous catheters as a source of hemodialysis-related bacteremia
    Taylor, GD
    McKenzie, M
    Buchanan-Chell, M
    Caballo, L
    Chui, L
    Kowalewska-Grochowska, K
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1998, 19 (09): : 643 - 646
  • [24] Central Venous Catheters Complications in Pediatric Patients on Acute Hemodialysis
    Mraz, M.
    Gasparikova, S.
    Kurcinova, H.
    Podracka, L.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1943 - 1943
  • [25] Quantification of Lipoteichoic Acid in Hemodialysis Patients With Central Venous Catheters
    Pai, Amy Barton
    Garba, Adinoyi
    Neumann, Paul
    Prokopienko, Alexander J.
    Costello, Gabrielle
    Dean, Michael C.
    Narsipur, Sriram
    FRONTIERS IN MEDICINE, 2018, 5
  • [26] Transhepatic Central Venous Catheters for Long-Term Hemodialysis
    Erdogan, Cuneyt
    Aktas, Nimet
    Dusak, Abdurrahim
    Senkaya, Isik
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32 (04): : 1090 - 1096
  • [27] The Burden of Tunneled Central Venous Catheters for Hemodialysis in a County Hospital
    Pillado, Eric
    Korn, Abraham
    De Virgilio, Christian
    Bowens, Nina
    AMERICAN SURGEON, 2017, 83 (10) : 1095 - 1098
  • [28] NOSOCOMIAL INFECTIONS AS A RISK IN HEMODIALYSIS PATIENTS WITH CENTRAL VENOUS CATHETERS
    Gerasimovska, V.
    Oncevski, A.
    Sikole, A.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (07): : 424 - 424
  • [29] Right atrial thrombotic complications or central venous catheters in hemodialysis
    Gibbons, R
    Ribot, S
    Chen, CG
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A31 - A31
  • [30] Clinical and economical assessment of two central venous hemodialysis catheters
    de Laguerenne, Anne Grozieux
    Barrier, Frederique
    Decaudin, Bertrand
    Semjen, Elisabeth
    Resibois, Jean-Pierre
    Wierre, Laurence
    Horrent, Sandrine
    Azar, Raymond
    Odou, Pascal
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 467 - 467